Page 60 - Read Online
P. 60

Enrique et al. J Cancer Metastasis Treat 2019;5:54  I  http://dx.doi.org/10.20517/2394-4722.2019.20                          Page 5 of 16






















               Figure 4. Magnetic resonance imaging of a patient with multiple brain metastases. Axial T2 slice sequence shows perilesional edema in
               the junction of white and gray matter

               Table 1. Spectroscopy
                Metabolite/marker             Function        As found in brain metastases   Range (parts per million)
                Creatine               Metabolism                  Internal standard        3.0
                Choline                Cellular membrane turnover   Increased               3.2
                Lipids                 Necrosis                    Increased                0.9-1.4
                Lactate                Anaerobic metabolism/necrosis  Increased             1.3
                N-acetylaspartate      Neuronal viability          Decreased                2.0


               SPECTROSCOPY
               Spectroscopy is an MRI technique that allows the metabolic characteristics of lesions to be evaluated, which
               may help distinguish between benign lesions and malignant lesions which would be difficult to differentiate
               using MRI alone. Spectroscopy can be performed for single or multiple tumor regions (unique voxel or
               multivoxel) to detect certain ranges of specific metabolites in brain tissue, such as choline, creatinine, lipids,
               lactate, and N-acetyl-aspartate (NAA) [22,23] .


               The analysis of these metabolites is helpful for distinguishing metastasis from necrosis, gliosis, and vasogenic
               edema [Table 1].


               Creatine is the most stable metabolite in brain tissue, although it can be diminished in malignant primary
               tumors such as high-grade gliomas. It is present in both white and gray matter, which enables it to be used as
               an internal reference for the remainder of metabolites, which can change in the context of metastatic brain
               disease [24,25] .

               Choline is a marker of cell change: it is a structural part of cell membrane phospholipids, with a greater
               presence in white matter than in gray matter. It is elevated where there are high-grade cell changes, and
               it has a relationship with creatine, such that both appear elevated, which helps orient a diagnosis of brain
               metastasis .
                        [26]

               Because lipids are a structural component of cell membranes, they appear elevated in the case of severe
               cell damage, even with necrosis. Lactate is a main metabolite associated with anaerobic metabolism, and
               necrosis is common in brain metastases . NAA is found at high concentrations in normal brain tissue,
                                                  [26]
               making it a marker for cell integrity and normal tissue structure; this marker appears at low concentrations
               in brain metastases [25,26] .
   55   56   57   58   59   60   61   62   63   64   65